Stock Watch: Pharma Businesses That Leave Consumer Behind
Corporate Simplification Risks Discarding Some Valuable And Defensive Attributes
Executive Summary
Healthcare conglomerates that divorce consumer, animal health and even generics businesses from their pure-play branded pharmaceutical groups could leave a less diversified and riskier sector in uncertain times. But the advantages are apparent.